Medicare will pay about $6,000 more for each procedure using two novel sutureless valves in fiscal 2018, the US Centers for Medicare and Medicaid Services announced Aug. 3. The valves, which are manufactured by Edwards Lifesciences Corp. and LivaNova PLC, were the only devices to request and obtain hospital inpatient new-technology add-on payment for the upcoming year.
The announcement came as part of the FY 2018 Medicare Hospital Inpatient Prospective Payment System and Long Term Acute Care Hospital Prospective Payment System Final Rule, which outlines...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?